📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Defining the immunogenicity of embryonic stem cell-derived dopaminergic progenitors as a cell replacement therapy for Parkinson's disease (2019)

First Author: Qarin Shamma

Attributed to: The Pluripotent Stem Cells and Engineered Cell (PSEC) Hub funded by MRC

Abstract

No abstract provided

Bibliographic Information

Type: Conference/Paper/Proceeding/Abstract